Diabetes and cancer: Looking at the multiligand/RAGE axis
- PMID: 21860695
- PMCID: PMC3158864
- DOI: 10.4239/wjd.v2.i7.108
Diabetes and cancer: Looking at the multiligand/RAGE axis
Abstract
The association between diabetes and hyperglycemia and the associated increased risk of several solid and hematologic malignancies has been the subject of investigation for many years. Although the association is not fully understood, current knowledge clearly indicates that diabetes may influence malignant cell transformation by several mechanisms, including hyperinsulinemia, hyperglycemia and chronic inflammation. In this context, the receptor for advanced glycation end-products (RAGE) has emerged as a focal point in its contribution to malignant transformation and tumor growth. We highlight how RAGE, once activated, as it manifests itself in conditions such as diabetes or hyperglycemia, is able to continuously bring about an inflammatory milieu, thus supporting the contribution of chronic inflammation to the development of malignancies.
Keywords: Cancer; Diabetes; Inflammation; Malignant transformation; Receptor for advanced glycation end-products.
Figures
Similar articles
-
Contribution of RAGE axis activation to the association between metabolic syndrome and cancer.Mol Cell Biochem. 2021 Mar;476(3):1555-1573. doi: 10.1007/s11010-020-04022-z. Epub 2021 Jan 4. Mol Cell Biochem. 2021. PMID: 33398664 Review.
-
Possible participation of receptor for advanced glycation end products (RAGE) in the origin of cancer stem cells in diabetic patients with colon cancer.Med Hypotheses. 2013 May;80(5):620-3. doi: 10.1016/j.mehy.2013.02.004. Epub 2013 Mar 5. Med Hypotheses. 2013. PMID: 23466064
-
Implications of receptor for advanced glycation end products for progression from obesity to diabetes and from diabetes to cancer.World J Diabetes. 2023 Jul 15;14(7):977-994. doi: 10.4239/wjd.v14.i7.977. World J Diabetes. 2023. PMID: 37547586 Free PMC article. Review.
-
Fueling inflammation at tumor microenvironment: the role of multiligand/RAGE axis.Carcinogenesis. 2010 Mar;31(3):334-41. doi: 10.1093/carcin/bgp322. Epub 2009 Dec 22. Carcinogenesis. 2010. PMID: 20028726 Review.
-
Receptor for Advanced Glycation End Products Acts as a Fuel to Colorectal Cancer Development.Front Oncol. 2020 Sep 29;10:552283. doi: 10.3389/fonc.2020.552283. eCollection 2020. Front Oncol. 2020. PMID: 33117687 Free PMC article. Review.
Cited by
-
Diabetes Mellitus Is a Strong Independent Negative Prognostic Factor in Patients with Brain Metastases Treated with Radiotherapy.Cancers (Basel). 2023 Oct 4;15(19):4845. doi: 10.3390/cancers15194845. Cancers (Basel). 2023. PMID: 37835539 Free PMC article.
-
[Diabetes mellitus and the female reproductive system tumors].Probl Endokrinol (Mosk). 2023 Jun 30;69(3):103-110. doi: 10.14341/probl13282. Probl Endokrinol (Mosk). 2023. PMID: 37448252 Free PMC article. Russian.
-
The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells.J Exp Clin Cancer Res. 2023 Jul 12;42(1):164. doi: 10.1186/s13046-023-02747-5. J Exp Clin Cancer Res. 2023. PMID: 37434266 Free PMC article.
-
Receptor of advanced glycation end-products axis and gallbladder cancer: A forgotten connection that we should reconsider.World J Gastroenterol. 2022 Oct 21;28(39):5679-5690. doi: 10.3748/wjg.v28.i39.5679. World J Gastroenterol. 2022. PMID: 36338887 Free PMC article. Review.
-
Assessing the Mechanism of Action of "Fructus Ligustri Lucidi-Cuscutae Semen" in Prostate Cancer Treatment Using Network Pharmacology and Molecular Docking.Comput Math Methods Med. 2022 Oct 25;2022:7543619. doi: 10.1155/2022/7543619. eCollection 2022. Comput Math Methods Med. 2022. PMID: 36330452 Free PMC article.
References
-
- van Dieren S, Beulens JW, van der Schouw YT, Grobbee DE, Neal B. The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil. 2010;17 Suppl 1:S3–S8. - PubMed
-
- Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R. Diabetes and cancer. Endocr Relat Cancer. 2009;16:1103–1123. - PubMed
-
- Shinohara M, Thornalley PJ, Giardino I, Beisswenger P, Thorpe SR, Onorato J, Brownlee M. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest. 1998;101:1142–1147. - PMC - PubMed
-
- Kislinger T, Fu C, Huber B, Qu W, Taguchi A, Du Yan S, Hofmann M, Yan SF, Pischetsrieder M, Stern D, et al. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem. 1999;274:31740–31749. - PubMed
LinkOut - more resources
Full Text Sources
